Nasdaq: CRSP
CRISPR Therapeutics AG insiders
The officers, directors and 10% owners of CRISPR Therapeutics AG who hold the most stock, valued at the live CRSP price.
$38.93
CRSP today −$1.3M (−3.14%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 2
- Their CRSP stock
- $12.6M
- Market value
- $3.78B
- Held by ranked insiders
- 0.33%
Insiders by value of CRSP holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Samarth Kulkarni | Chief Executive Officer | 297,521 | $11.6M | 0.31% | 7861st |
| 2 | Lawrence Klein | CBO & COO | 26,797 | $1.0M | <0.1% | 1613th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for CRISPR Therapeutics AG; see each profile for the filing.